• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of Experimental & Clinical Cancer Research

    Journal of Experimental & Clinical Cancer Research

    JournalISSN 0392-9078eISSN 1756-9966中科院 医学 1区

    年发文量

    研究主题

    论文(6259)

    排序
    1NewCOMP-MUC1 Interaction Mediated by the Arg628-Asp543 Salt Bridge Confers Ferroptosis Resistance to Drive Prostate Cancer Bone Metastasis
    Linjie Wu, Leijie Wang, Kunhao Liu,Xiaojie Bai, Zihao Qi,Wang Ye,Zhongqiang Guo,Ying Yu

    Metastasis is the leading cause of mortality in prostate cancer (PCa), with bone being the most common site of dissemination. The survival of tumor cells in the circulation following detachment from the extracellular matrix (ECM) is an essential prerequisite for cancer metastasis, yet the underlying mechanisms remain incompletely understood. To investigate the cellular adaptations that support survival under ECM-detached conditions, we established detachment-resistant (DR) models using PC-3 and LNCaP cells. COMP expression was examined in PCa clinical tissues and DR cells. Functional and mechanistic studies were then performed both in vitro and in vivo. COMP was highly expressed in PCa tissues and DR PCa cells. COMP upregulation promoted ferroptosis resistance by reducing intracellular Fe²⁺ accumulation and lipid peroxidation, thereby facilitating PCa progression and metastasis. Mechanistically, COMP directly bound to mucin 1 (MUC1) via a high-affinity Arg628-Asp543 salt bridge, which promoted MUC1 phosphorylation and enhanced its signaling activity. p-MUC1 subsequently inhibited the Hippo signaling pathway, promoting nuclear translocation of Yes-associated protein 1 (YAP1). YAP1 cooperated with TEAD transcription factors to drive transcription of nuclear protein 1 (NUPR1), which activated lipocalin-2 (LCN2), an iron-transporting protein that critically regulates intracellular iron homeostasis and redox balance, thereby conferring ferroptosis resistance. Importantly, suppressing COMP significantly inhibited PCa bone and lung metastasis in vivo. This study reveals that COMP facilitates PCa bone metastasis by enhancing ferroptosis resistance through the MUC1/YAP1/NUPR1/LCN2 axis, suggesting that inhibition of COMP combined with ferroptosis activators may represent a promising therapeutic strategy to suppress PCa bone metastasis.

    2026
    引用
    AI阅读
    加入学术空间
    2NewTargeting the Splicing Factor RBM39 Reduces Mitotic Fidelity and Enhances Taxane Cytotoxicity in Triple Negative Breast Cancer Cells
    Vanessa Medici,Cinzia Caggiano,Ludovica Altieri, Claudia Mancini, Alessandra Ciucci, Eleonora Kristina Scarpone, Claudia Landolfo, Mohammad Salik Zeya Ansari,Eleonora Cesari, Giacomo Milletti, Emanuele Panatta, Alba Di Leone,

    Triple-negative breast cancer (TNBC) accounts for 15

    2026
    引用
    AI阅读
    加入学术空间
    3NewAdvillin Stabilizes YAP to Sustain Oncogenic Transcription and Creates Therapeutic Vulnerability in Rhabdomyosarcoma
    Martyna Glowczyk-Gluc,Shafaque Zahra, Summer Johnson,Zhongqiu Xie,Yiwei Wang, Mengling Ye, Julie Fanburg-Smith,Robin D. LeGallo, Eyas Alzayadneh,Hui Li

    Rhabdomyosarcoma (RMS) is the most common pediatric soft-tissue sarcoma. Despite intensive multimodal therapy, outcomes remain poor for patients with metastatic or recurrent disease, underscoring an urgent need for novel molecularly targeted therapies. We previously identified advillin (AVIL), a gelsolin family actin-binding protein, as a novel oncogenic driver overexpressed in RMS and associated with poor clinical outcomes. However, the downstream molecular mechanisms by which AVIL drives and sustains oncogenic signaling in RMS have remained unclear. Here, we investigated AVIL-dependent regulation of the Hippo pathway effector Yes-associated protein (YAP) and the therapeutic relevance of the AVIL–YAP axis in RMS. AVIL expression was evaluated in clinical RMS specimens across histologic subtypes, tumor grades, and clinical stages. Transcriptomic, molecular, and functional analyses investigated AVIL-dependent YAP regulation in RMS cells, mesenchymal stem cells, and patient-derived models. Therapeutic dependency on the AVIL–YAP signaling axis was assessed using genetic and pharmacologic approaches in vitro and in patient-derived xenograft models. Statistical analyses included unpaired two-tailed t-tests, one-way ANOVA, log-rank (Mantel–Cox) tests, and REML-based mixed-effects models. Nonlinear regression determined IC₅₀ values. AVIL was broadly expressed across RMS specimens spanning stages, grades, and subtypes, and functioned as an upstream regulator of the Hippo effector YAP. AVIL promoted YAP stabilization and nuclear accumulation, enhancing YAP-dependent transcription alongside altered Hippo pathway regulation. Genetic AVIL depletion impaired YAP signaling and RMS cell survival, while promoting myogenic differentiation. Actin perturbation diminished AVIL-associated nuclear YAP, and mutations affecting AVIL actin-regulatory functions attenuated YAP activity and suppressed proliferation and migration, supporting a role for actin remodeling in AVIL-driven tumorigenesis. AVIL-high RMS models showed heightened sensitivity to YAP inhibition in vitro, whereas AVIL-depleted cells showed diminished responsiveness. Pharmacologic YAP inhibition suppressed YAP-dependent transcription in vitro and reduced tumor incidence in AVIL-high RMS xenografts in vivo. Our findings identify a previously unrecognized AVIL–YAP axis that sustains oncogenic transcription and tumorigenic phenotypes in RMS. These results establish AVIL-mediated YAP dependency as a therapeutically actionable vulnerability and support targeting this pathway as a treatment strategy for aggressive RMS.

    2026
    引用
    AI阅读
    加入学术空间
    4NewSpatial Transcriptomics Identifies a B Cells–depleted Profile Underlying High-Risk Classical Hodgkin Lymphoma
    Benedetta Donati,Tanja Lazic,Riccardo Valli,Pierluigi Di Chiaro,Rexhep Durmo,Cristian Ascione,Attilio Gennaro,Alessia Ruffini,Manuel Gotti,Marco Paulli,Stefano Pozzi,Sonya De Lorenzo,

    Risk stratification in classical Hodgkin lymphoma (cHL) primarily relies on clinical and radiologic parameters, but outcomes are still heterogeneous after standard first-line chemotherapy. We investigated how, the spatial interplay between Hodgkin and Reed–Sternberg cells (HRS) and tumor microenvironment (TME) at diagnosis, impacts on clinical aggressiveness. Spatial transcriptomics was performed to profile HRS (CD30+), non-tumoral B cells (CD20+) and TME (CD45+/CD30-) in a matched series of cHLs, comparing 4 relapsed/refractory (R/R+) and 4 relapse-free (R/R-) patients. A retrospective monocentric training cohort (N = 155) and a multicentric retrospective validation cohort (N = 89) of cHLs were analyzed using digital barcoding-based gene-expression profiling of 770 immune-related genes, to derive and validate a biologically relevant gene score predictive of progression-free survival (PFS). A B-cell–related gene score (B-score) was developed using elastic net regression. Spatial transcriptomics showed that R/R+ cHLs exhibited loss of B-cell lineage identity in HRS cells and marked depletion of naïve B cells in TME. Digital barcoding transcriptomic analysis in the training cohort (4-year PFS 80.4

    2026
    引用
    AI阅读
    加入学术空间
    5NewERG Inhibition Selectively Sensitizes ERG-positive Prostate Cancer to Radiation Through DNA Repair Vulnerabilities and Enhances Response to Androgen Receptor Inhibitors
    Ayham Moustafa,Mohamed E. Elsesy,Bente Siebels,Jan Hahn,Su-Jung Oh-Hohenhorst, Carlotta Schudy,Thorsten Rieckmann,Susanne Burdak-Rothkamm,Derya Tilki,Tobias Maurer,Cordula Petersen,Kai Rothkamm,

    ERG overexpression, driven by TMPRSS2-ERG gene fusion, occurs in 50

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 6259 篇论文

    高被引作者

    作者引用发文
    Rebecca Shin Yee Wong40412
    Wei Xiong221414
    Guiyuan Li210211
    Zhaoyang Zeng207511
    Qianjin Liao183410
    Bo Xiang13806
    Fang Xiong13405
    ZhaoJian Gong13405
    Jun Soga123126
    Francesco Cognetti120724

    高产作者

    作者引用发文
    Giovanni Blandino97141
    Giannarelli Diana93332
    Isabella Sperduti115531
    Gennaro Ciliberto82328
    Jun Soga123126
    Francesco Cognetti120724
    Yong Teng98721
    Stavroula Tsiara22221
    Sacconi Andrea27918
    Kuttan Girija77518

    相关期刊

    Cancer Letters
    Oncogene
    Oncology reports
    International journal of oncology
    Cancer cell international
    Molecular cancer
    Cancer science
    OncoTargets and therapy
    Journal of Cancer
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer